Skip to main content
News Kolanus 04.2022
ImmunoSensation speaker Prof. Dr. Waldemar Kolanus (left) and Dr. Stefan Weise from the LIMES Institute (right).
© Barbara Fomman / Uni Bonn

News categories: Publication

Surprising finding on the cause of hydrocephalus

Prof. Dr. Waldemar Kolanus, speaker of the Cluster of Excellence ImmunoSensation2, together with an international team of scientists, shows that hydrocephalus is often caused by disrupted brain development.

Hydrocephalus in children often has completely different causes than previously assumed. This is the conclusion of an international study with a substantial participation by the University of Bonn. The researchers identified a series of mutations that cause disruption of early brain development. The characteristic enlargements of the fluid-filled cavities in the brain are a consequence of this. The study was led by Yale, Harvard and Bonn Universities; its findings also have implications for the diagnosis and treatment of this serious condition. The results are published in the journal Nature Neuroscience.

One in 1,000 children is born with hydrocephalus. The serious condition is the most common reason for brain surgery in childhood. Nevertheless, those affected often suffer from intellectual and motor impairments for the rest of their lives.

A paradigm shift

In hydrocephalus, the fluid-filled cavities in the brain, the ventricles, are significantly enlarged. This significantly increases the intracranial pressure. The cause is thought to be disruptions of the cerebrospinal fluid balance. This fluid surrounds the brain and removes toxins. It also acts like a cushion to protect the brain from shocks and ensures that the cavities do not collapse. "Until now, it was thought that in hydrocephalus too much CSF was formed or too little was discharged, or that its onward transport was simply impaired," explains Prof. Dr. Waldemar Kolanus of the LIMES Institute at the University of Bonn. "However, our results now point in a different direction."

93 risk genes identified

In children, the condition is usually genetic; however, the hereditary factors responsible are only partially known. The researchers from Harvard and Yale therefore sequenced the genome of almost 500 patients and compared it with the genetic material of healthy individuals. In the process, they came across 93 genes in which mutations lead to hydrocephalus. "Surprisingly, none of these genes are involved in any way in CSF production or transport," emphasizes Kolanus' collaborator Dr. Stefan Weise, one of the two lead authors of the study. "Instead, they seem to be mostly related to brain development."

One hereditary trait that was particularly often mutated in affected individuals is the TRIM71 gene. "We have been studying this gene here in Bonn for several years," Kolanus says. "This is also the reason why our U.S. colleagues contacted us." The international team also introduced the mutations they found into the TRIM71 gene in mice. The model animals then also developed hydrocephalus.

"We then used stem cells here in Bonn to reproduce very early events of brain development in cell culture," Kolanus explains. "This allowed us to show that hydrocephalus mutations of TRIM71 specifically affect these functions. In the future, we will decipher these processes even better with the help of organoids, which are cell clusters that roughly resemble a very simple brain."

Mutations probably make the brain more mechanically unstable

The mutations presumably damage the so-called neuroepithelial cells. These line the fluid cavities in the brain from the inside. "We assume that these changes make the neuroepithelium thinner and more mechanically flexible, and that the cavities increase as a result," Stefan Weise believes. "This can then lead to increased cerebrospinal fluid accumulation and thus also to increased intracranial pressure." In this case, hydrocephalus is therefore a consequence of neurodevelopmental disorders in early childhood, which in turn are responsible for the cognitive impairments of the young patients.

Usually, hydrocephalus surgery involves the use of a so-called shunt system through which the excess cerebrospinal fluid can be drained. This reduces the pressure in the skull, and accompanying symptoms such as headaches or visual disturbances disappear. However, the cognitive and intellectual limitations usually persist. "Our results explain why this is the case in congenital hydrocephalus," Kolanus says. "The damage doesn't come from increased pressure, but occurs much earlier, during embryonic brain development."

This finding might also have therapeutic consequences. For instance, the insertion of the shunt system is not without risks. Nevertheless, many medical professionals advise it because they fear that the brain abnormalities will otherwise increase. “However, the procedure is probably not useful in all cases in children," says Kolanus.

It may in future also be possible to diagnose hydrocephalus before birth using genetic testing. Targeted early intervention could then possibly prevent some damage. However, the condition is unlikely to be curable in the foreseeable future. "This would require gene therapy of the embryo in the womb," Kolanus explains. "Right now, it would be way too risky and also legally impossible."

The researcher is one of the spokespersons for the Cluster of Excellence ImmunoSensation2 and the Transdisciplinary Research Area (TRA) “Life and Health” at the University of Bonn. "For this project, which as so often relies on the cooperation of many groups, I was able to draw on the excellent networks in the Cluster of Excellence and the TRA," he adds.


Participating institutions and funding

In addition to the Universities of Yale, Harvard and Bonn, as well as the German Center for Neurodegenerative Diseases (DZNE) in Bonn and the Humboldt University of Berlin, various universities and clinics in Great Britain and the USA were involved in the study. The work was financially supported by the National Institutes of Health (USA) and the German Research Foundation (DFG), among others.


Publication

Phan Q. Duy, Stefan C. Weise et al.: Impaired neurogenesis alters brain biomechanics in a neuroprogenitor-based genetic subtype of congenital hydrocephalus; Nature Neuroscience; https://doi.org/10.1038/s41593-022-01043-3


Contact

Prof. Dr. Waldemar Kolanus
Life and Medical Sciences Institute (LIMES) at the University of Bonn
Phone: +49-228-7362790
Email: wkolanus@uni-bonn.de

Related news

Prof. Christian Strassburg, Direktor der Klinik für Allgemeine Innere Medizin am UKB, mahnt: „Die Abnehmpille ist nicht einfach nur irgendein Spaßfaktor, um jetzt ein bisschen abzunehmen!“

News categories: Publication

Weight-Loss Pill Instead of Injection: Finally, an Easy Way to Lose Weight?

As of September 1, semaglutide will be available in Germany for the treatment of overweight and obesity in tablet form for the first time. The therapy, previously known primarily as a “weight-loss injection,” can now also be taken orally. The market launch is likely to attract considerable interest – but anyone considering treatment should be aware of one thing first: the tablet is not a way to lose a few kilos, but a prescription medication for the treatment of a chronic disease.
View entry
Prof. Matthias Geyer, - together with Prof. Robert P. Fisher from New York, provides an overview of the current state of research on the transcriptional regulation of cyclin-dependent kinases (CDKs) and the prospects for cancer treatment.

News categories: Publication

A Ray of Hope in the Fight Against Cancer

Cancer is the second leading cause of death in Germany. In the search for new therapeutic approaches that target the uncontrolled growth of tumor cells, a class of enzymes known as cyclin-dependent kinases (CDKs) has come into focus. This is because this family of enzymes plays a fundamental role in gene expression and cell division. An overview of the current state of research on the transcriptional regulation of CDKs and the prospects for cancer treatment was compiled by Prof. Matthias Geyer of the UKB in collaboration with Prof. Robert P. Fisher and has now been published.
View entry
(from left) Julia Nicke and Dr. Mona Malek Mohammadi have identified a previously unknown signaling pathway in the immune system that helps newborn heart cells survive and regenerate after injury.

News categories: Publication

Central Hub for Heart Repair Discovered Bonn study: Heart muscle interaction enables cardiac regeneration in the neonatal heart

Researchers at the University Hospital of Bonn (UKB) and the University of Bonn have identified a previously unknown signaling pathway in the immune system that helps newborn heart cells survive and regenerate after injury. The findings could open new avenues for future therapies aimed at repairing damaged adult hearts after heart attacks or chronic cardiovascular disease. The study has now been published in the journal Cell Communication and Signaling (Springer Nature).
View entry

Back to the news overview